Very glad to present our data on pre-clinical validation for the discovery of a novel CAR-T therapy for mutCALR Myelofibrosis in such an amazing meeting #ESHMPN2024

Many thanks to Claire Roddie, Martin Pule, Jon Lambert and Beth Psaila for their ongoing support

UCL Cancer Institute

Discussing again and again with young trainees at #EBMT24 : our work is about PASSION. The passion to discover, to learn, to heal, to cure, to transmit and share knowledge. The rest is less important. Distance yourself from the sanctimonious people only showing-off. Anne Parker

Sad but true:

Same data and different reach...

Established institute with world known senior👉journal impact factor >10

LMIC institute👉impact factor <3

Another great lecture by Mohamad Mohty The EBMT #ebmt24 at the educational session of ALWP. GvHD Prophylaxis. A lot going on. Outcomes are improving. “PTCY has come to stay…”

It never gets old! That feeling of excitement when you hang your poster, result of several hours of hard work! Come to the poster session B092 & let’s discuss strategies to optimise conditioning of 2nd alloSCT for relapsed AML! The EBMT #EBMT24

A resounding start to the third day of #EBMT24 with Gesine Bug discussing the revisited indications of allo in AML 👏🏻 #ALWP The EBMT The EBMT_Trainee

Simona Pagliuca is the best to make you digest in the easiest way possibile the intricacies of post-HCT immunological monitoring .. wonderful! #EBMT24 The EBMT

This figure/ slide is amazing

BMT CTN 1801 scientific update presented by Leslie Kean in the presidential symposium The EBMT with fascinating deep insights into biological effects following PTCY use - congratulations BMT CTN !@DrLeslieKean #EBMT24

Congress | #EBMT24 Gesine Bug, Goethe-Universität highlights a retrospective analysis of outcomes of patients with NPM1-mut AML with MRD persistence or relapse who received allo-HSCT. Patients with molecular recurrence in CR1 transplanted before progressing to hematological relapse had…

Agree 100% one of the best talks I’ve been to this Meeting

Immune monitoring in setting of CART, why and what?🤪

The wonderful Simona Pagliuca guides through this labyrinth
#EBMT24 The EBMT Trainee Committee

Con el JEFE! Paraguay 🇵🇾 in the house at the #EBMT24 meeting The EBMT Cristobal Frutos

Enjoyed this presentation by Simona Pagliuca from the beginning to the end! Very practical recommendations for relapse prevention post transplant in AML

Here we go Glasgow, here we go #EBMT24 👌

The EBMT The EBMT_Trainee

Do you wanna know everything about management of AML relapsing post-HCT ?
A full room for a terrific talk by Simona Pagliuca at #EBMT24 The EBMT The EBMT_Trainee The EBMT_CTIWP

The day has finally arrived - welcome to the much awaited 50th Annual Meeting of the EBMT! 🎉 #EBMT24

Interesting methods description of this BMT paper from 1998 “patients vomiting had the dose repeated… those vomiting two doses-> nasoduodenal tube!” Conditioning for SCT was somehow aggressive in the 90’s. Been in working in SCT since 2020, haven’t seen Busulfan p.o. anymore.

Congratulations Santhiago BdP #34209 and colleagues for successfully publishing your Report on the rescue and reinstate of a vulnerable/ threatened species in South America on Veterinary Medicine and Science. Guys in Asuncion-Paraguay are doing a great job in medical veterinary 👏🏻

Impressive CR rates of >90% in newly diagnosed FLT3 AML non eligible for intensive treatment, with 1,5years duration of remission. This is progress in Hematology. These are good news.